Geographic footprint Atlas Global Brands operates across Canada, Israel and eight additional countries with a diversified brand portfolio and distribution channels, presenting cross-border selling opportunities for cannabis products, ancillary services, and export-ready formats.

Licensed facilities Two fully accredited facilities, including an EU-GMP site and a facility with GACP & CUMCS certification, signal strong quality assurances and potential for premium product offers, contract manufacturing, and white-label partnerships.

Recent restructuring Significant office closures and headcount reductions in 2023–2024 indicate transformation; opportunities may exist to assist in supply chain optimization, regulatory compliance services, manufacturing efficiency, and asset reutilization or redeployment.

Strategic partnerships Past collaborations with high-profile brands and licensing agreements (notably with Snoop Dogg) highlight openness to co-branding, exclusive product launches, and international licensing deals that can be leveraged for new market entries and co-marketing initiatives.

Revenue traction Current revenue range of 1–10 million with a diverse value-chain footprint suggests potential addressable markets in cultivation, manufacturing, distribution, and pharmacy services; approach should target scalable, high-margin offerings and cross-sell across geographies.